FierceBiotechOriginal article
{"a":[{"_":"AstraZeneca pens $1.7B kidney drug discovery pact with go-to Chinese partner CSPC","$":{"href":"/biotech/astrazeneca-pays-go-chinese-partner-cspc-30m-form-kidney-drug-discovery-pact","hreflang":"en"}}]}
PartnershipPositive
AI Analysis
Summary
AstraZeneca and CSPC Pharmaceutical have entered into a kidney drug discovery and development partnership with AstraZeneca paying $30 million upfront to jointly develop two kidney disease drug candidates.
Importance:6/10
Sentiment:
0.40
partnershipdrug discoverykidney diseaseChinacollaboration
Related Companies
Read the original article
Published by FierceBiotech on July 3, 2026 4:26 AM